An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …

Pemphigus is an epidemiologically heterogeneous group of autoimmune bullous diseases
comprising pemphigus vulgaris (PV), pemphigus foliaceus, paraneoplastic pemphigus, IgA …

Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Clinicians may encounter a variety of skin conditions that present with vesiculobullous
lesions in their everyday practice. Pemphigus vulgaris, pemphigus foliaceus, IgA …

Background Pemphigus vulgaris and pemphigus foliaceus are potentially life‐threatening
autoimmune disorders triggered by IgG autoantibodies against mucosal and epidermal …

Background Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris, but
they have not been adequately compared in clinical trials. Methods In a randomized …

Bruton's tyrosine kinase (BTK), a member of the Tec kinase family, is critically involved in a
range of immunological pathways. The clinical application of BTK inhibitors for B‐cell …

Background Paraneoplastic pemphigus (PNP), also called paraneoplastic autoimmune
multiorgan syndrome (PAMS), is a rare autoimmune disease with mucocutaneous and multi …

Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and
daily routine around the world. Huge efforts from pharmacological industries have led to the …

Pemphigus represents a group of rare and severe autoimmune intra-epidermal blistering
diseases affecting the skin and mucous membranes. These painful and debilitating diseases …